Immune response to varicella-zoster virus glycoproteins in guinea pigs infected with Oka varicella vaccine

By Sato H.   Kageyama S.   Imakita M.   Ida M.   Yamamura J.-i.   Kurokawa M.   Shiraki K.  

Vaccine, Vol. 16, Iss. 13, 1998-08 ,pp. : 1263-1269

Elsevier

Access to resources Recommend Favorite

Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation

By Jacquet A.   Haumont M.   Massaer M.   Garcia L.   Mazzu P.   Daminet V.   Gregoire D.   Jacobs P.   Bollen A.  

Vaccine, Vol. 20, Iss. 11, 2002-02 ,pp. : 1593-1602

Elsevier

Access to resources Recommend Favorite

Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine

By Sato H.   Yamamura J.-i.   Kageyama S.   Kurokawa M.   Shiraki K.  

Vaccine, Vol. 22, Iss. 1, 2003-12 ,pp. : 15-20

Elsevier

Access to resources Recommend Favorite

Immunization with a DNA vaccine expressing a truncated form of varicella zoster virus glycoprotein E

By Hasan U.A.   Harper D.R.   Wren B.W.   Morrow W.J.W.  

Vaccine, Vol. 20, Iss. 9, 2002-01 ,pp. : 1308-1315

Elsevier

Access to resources Recommend Favorite

Nucleotide sequence analysis of varicella-zoster virus glycoprotein E epitope coding regions

By Shankar V.   Fisher S.   Forghani B.   Vafai A.  

Vaccine, Vol. 19, Iss. 28, 2001-07 ,pp. : 3830-3833

Elsevier

Access to resources Recommend Favorite